Genentech Triples Lease At Harvard's Allston Research Campus

Courtesy of Tishman Speyer
A rendering of Tishman Speyer and Breakthrough Properties' One Milestone St., a two-building lab complex at Harvard Enterprise Research Campus in Allston.

Tishman Speyer and Breakthrough Properties secured a lease expansion for a planned innovation center at the Harvard Enterprise Research Campus in Allston.

Roche Genentech will triple its size at the ERC from 30K SF to 100K SF for the innovation center, according to a press release. The company plans to begin a phased move-in starting in mid-2026.

The pharmaceutical company first announced plans to move onto the campus in March and occupy 30K SF at Tishman's two-building life sciences complex at One Milestone St. In its March release, Genentech said it ultimately hoped to hire up to 500 employees for the location.

Its planned innovation center within the lab building will serve as a hub for its research into cardiovascular, renal and metabolism medicine.

"The forthcoming Innovation Center is an ideal anchor for One Milestone and a powerful representation of that very mission,” Tishman Speyer CEO Rob Speyer said in a statement.

One Milestone is in the latter stages of construction, according to the press release.

The two buildings are interconnected and include a 265K SF east wing and a 245K SF west wing. The property is part of Tishman Speyer's larger 900K SF first phase of the ERC. Plans for the project include a 343-unit apartment building and a hotel.

Harvard University chose Tishman Speyer to develop the project in 2019.

Genentech was acquired by pharmaceutical giant Roche in 2009 for $46.8B. The company has been expanding elsewhere, including North Carolina, where it plans to double its investment to $2B, Reuters reported. The North Carolina facility will open in Holly Springs in 2029.

In July, Genentech planned a massive overhaul of the company's 207-acre San Francisco campus costing upward of $5B. However, the company also had several rounds of layoffs over the past two years, shedding more than 800 employees.

The lease expansion comes at a time of high vacancy across the overall market, which stood at 34% in the fourth quarter, according to Cushman & Wakefield. The urban ring submarket, which Allston is part of, saw 54.8% vacancy.

UPDATE, JAN. 23, 4 P.M. ET: Cushman & Wakefield's Greater Boston vacancy figure was added.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Why DivcoWest Is Advancing A New 19-Story Lab Development In Somerville

Massachusetts Housing Projects Receive $278M In New Public Funding

Downtown Office Building Approved For Conversion Trades For $8.5M: The Boston Deal Sheet

Lab Landlords In 'Hand-To-Hand Combat' To Last To Recovery

'This Is A Big Change For Me': Leslie Cohen Launching New Company After Leaving Davis Cos.

The Pain In NYC's Biotech Market Is Hitting Harlem Hardest

Healey Awards $15M To Help Advance 5 Residential Conversion Projects

A Mindful Approach To Building In Specialized Environments

Downtown Office Tower Secures $575M Refinancing

City Realty Buys Coolidge Corner Portfolio For $23M: The Boston Deal Sheet

Revolution Medicines Nearing Agreement For 700K SF Lease In Redwood City

Alexandria Sells Cambridge Lab Condo Units For $45M